Researchers from the University of Technology Sydney (UTS), together with biotech firm Regeneus, have created what they claim is the world’s first 3D printed microfluidic device capable of harvesting stem cells. Bleeding-edge stem cell therapies are a promising way to treat a whole plethora of ailments, including arthritis, diabetes, and potentially even cancer. Stem cells work by differentiating into specialized cells, meaning they can be used to replace damaged cells around the human body. Unfortunately, harvesting and processing stem cells from donors is currently very time, cost, and labor intensive due to limitations in biotechnology. The 3D printed microfluidic device is designed to harvest stem cells from bioreactors, offering a scalable method of processing stem cells without the associated costs. Professor Majid Warkiani, the UTS biomedical engineer leading the research, said, “Our cutting-edge technology, which uses 3D printing and microfluidics to integrate a number of production steps into one device… read more